In Vitro Evaluation of Arylsulfonamide Derivatives against Trypanosoma cruzi
Abstract
:1. Introduction
2. Results and Discussion
3. Conclusions
4. Materials and Methods
4.1. Charcterization Data
4.2. Anti-Trypanosoma cruzi Activity Assay (Amastigotes and Trypomastigotes)
4.3. In Vitro Cytotoxic Test of Trypanocidal Compounds
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Nabavi, F.S.; Sureda, A.; Daglia, M.; Izadi, M.; Rastrelli, L.; Nabavi, S.M. Flavonoids and Chagas’ Disease: The Story So Far! Curr. Top. Med. Chem. 2017, 17, 460–466. [Google Scholar] [CrossRef] [PubMed]
- Coura, J.R. Tripanosomose, Doença de Chagas. Ciênc. Cult. 2003, 55, 30–33. [Google Scholar]
- World Health Organization. Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Tropical Diseases; World Health Organization (WHO): Geneva, Switzerland, 2015; Volume 3, p. 191. ISBN 978 92 4 156486 1. [Google Scholar]
- World Health Organization (WHO). Chagas Disease. Available online: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) (accessed on 15 April 2023).
- Schmunis, G.A. Epidemiology of Chagas disease in non endemic countries: The role of international migration. Mem. Inst. Oswaldo Cruz 2007, 102, 75–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ribeiro, A.L.; Nunes, M.P.; Teixeiras, M.M.; Rocha, M.O. Diagnosis and management of chagas disease cardiomyopathy. Nat. Rev. 2012, 10, 576–589. [Google Scholar] [CrossRef]
- McGonagle, K.; Tarver, G.J.; Cantizani, J.; Cotillo, I.; Dodd, P.G.; Ferguson, L.; Thomas, M.G. Identification and development of a series of disubstituted piperazines for the treatment of Chagas disease. Eur. J. Med. Chem. 2022, 238, 114421. [Google Scholar] [CrossRef]
- Lima, M.L.; Tulloch, L.B.; Corpas-Lopez, V.; Carvalho, S.; Wall, R.J.; Milne, R.; Ric, E.; Patterson, S.; Gilbert, I.H.; Moniz, S.; et al. Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas’ disease. Antimicrob. Agents Chemother. 2022, 66, e01535-21. [Google Scholar] [CrossRef]
- Mercaldi, G.F.; Eufrásio, A.G.; Ranzani, A.T.; do Nascimento Faria, J.; Mota, S.G.; Fagundes, M.; Cordeiro, A.T. Trypanosoma cruzi Malic Enzyme Is the Target for Sulfonamide Hits from the GSK Chagas Box. ACS Infect. Dis. 2021, 7, 2455–2471. [Google Scholar] [CrossRef]
- Vieira, D.F.; Choi, J.Y.; Roush, W.R.; Podust, L.M. Expanding the Binding Envelope of CYP51 Inhibitors Targeting Trypanosoma cruzi with 4-Aminopyridyl-Based Sulfonamide Derivatives. ChemBioChem 2014, 15, 1111–1120. [Google Scholar] [CrossRef] [Green Version]
- Cassiano Martinho, A.C.; de Melo Resende, D.; Landin, E.S.; Dit Lapierre, T.J.W.J.; Bernardes, T.C.D.; Martins, L.C.; de Oliveira Rezende Júnior, C. Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi. ChemMedChem 2022, 17, e202200211. [Google Scholar] [CrossRef]
- Papadopoulou, M.V.; Bloomer, W.D.; Rosenzweig, H.S.; Chatelain, E.; Kaiser, M.; Wilkinson, S.R.; Ioset, J.R. Novel 3-nitro-1 H-1, 2, 4-triazole-based amides and sulfonamides as potential antitrypanosomal agents. J. Med. Chem. 2012, 55, 5554–5565. [Google Scholar] [CrossRef] [Green Version]
- Pan, P.; Vermelho, A.B.; Capaci Rodrigues, G.; Scozzafava, A.; Tolvanen, M.E.; Parkkila, S.; Supuran, C.T. Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease. J. Med. Chem. 2013, 56, 1761–1771. [Google Scholar] [CrossRef]
- Galiana-Rosello, C.; Bilbao-Ramos, P.; Dea-Ayuela, M.A.; Rolon, M.; Vega, C.; Bolas-Fernandez, F.; Gonzalez-Rosende, M.E. In vitro and in vivo antileishmanial and trypanocidal studies of new N-benzene-and N-naphthalenesulfonamide derivatives. J. Med. Chem. 2013, 56, 8984–8998. [Google Scholar] [CrossRef]
- Dolensky, J.; Hinteregger, C.; Leitner, A.; Seebacher, W.; Saf, R.; Belaj, F.; Weis, R. Antiprotozoal Activity of Azabicyclo-Nonanes Linked to Tetrazole or Sulfonamide Cores. Molecules 2022, 27, 6217. [Google Scholar] [CrossRef]
- Bocanegra-Garcia, V.; Carlos Villalobos-Rocha, J.; Nogueda-Torres, B.; Edith Lemus-Hernandez, M.; Camargo-Ordonez, A.; Maria Rosas-Garcia, N.; Rivera, G. Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents. Med. Chem. 2012, 8, 1039–1044. [Google Scholar]
- Junqueira, G.G.; Carvalho, M.R.; Andrade, P.D.; Lopes, C.D.; Carneiro, Z.A.; Sesti-Costa, R.; Carvalho, I. Synthesis and in vitro evaluation of novel galactosyl-triazolo-benzenesulfonamides against Trypanosoma cruzi. J. Braz. Chem. Soc. 2014, 25, 1872–1884. [Google Scholar]
- Taylor, J.G.; Whittall, N.; Hii, K.K. Copper-catalyzed intermolecular hydroamination of alkenes. Org. Lett. 2006, 8, 3561–3564. [Google Scholar] [CrossRef]
- Enantiopurity of 1aa was assessed by chiral HPLC (Conditions: Chiralcel OD-H, i-PrOH/hexane 10:90, flow rate 0.6 mL/min, tR= 16.8 min, ts = 20.4 min).
- Coelho, G.S.; Andrade, J.S.; Xavier, V.F.; Sales Júnior, P.A.; Rodrigues de Araujo, B.C.; Fonseca, K.D.S.; Caetano, M.S.; Murta, S.M.F.; Vieira, P.M.; Carneiro, C.M.; et al. Design, Synthesis, Molecular Modelling and In Vitro Evaluation of Tricyclic Coumarins Against Trypanosoma cruzi. Chem. Biol. Drug Des. 2019, 93, 337–350. [Google Scholar] [CrossRef]
- Elias, P.R.; Coelho, G.S.; Xavier, V.F.; Sales Junior, P.A.; Romanha, A.J.; Murta, S.M.F.; Carneiro, C.M.; Taylor, J.G. Synthesis of Xylitan Derivatives and Preliminary Evaluation of in Vitro Trypanocidal Activity. Molecules 2016, 21, 1342. [Google Scholar] [CrossRef] [Green Version]
- Maciel Diogo, G.; Andrade, J.S.; Sales Junior, P.A.; Maria Fonseca Murta, S.; Dos Santos, V.M.R.; Taylor, J.G. Trypanocidal activity of flavanone derivatives. Molecules 2020, 25, 397. [Google Scholar] [CrossRef] [Green Version]
- Andrade, J.S.; Junior, P.A.S.; Pereira, F.J.; Murta, S.M.F.; Correa, R.S.; Taylor, J.G. Trypanocidal activity of chromenepyrazole derivatives. Chem. Pap. 2022, 76, 5827–5837. [Google Scholar] [CrossRef]
- Romanha, A.J.; Castro, S.L.; Soeiro, M.N.; Lannes-Vieira, J.; Ribeiro, I.; Talvani, A.; Bourdin, B.; Blum, B.; Olivieri, B.; Zani, C.; et al. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz 2010, 105, 233–238. [Google Scholar] [CrossRef] [PubMed]
- Mahata, T.; Kanungo, A.; Ganguly, S.; Modugula, E.K.; Choudhury, S.; Pal, S.K.; Basu, G.; Dutta, S. The Benzyl Moiety in a Quinoxaline-Based Scaffold Acts as a DNA Intercalation Switch. Angew. Chem. Int. Ed. 2016, 55, 7733–7736. [Google Scholar] [CrossRef] [PubMed]
- Lovering, F. Escape from Flatland 2: Complexity and promiscuity. MedChemComm 2013, 4, 515–519. [Google Scholar] [CrossRef]
- Borah, A.J.; Phukan, P. A highly efficient catalyst-free protocol for C–H bond activation: Sulfamidation of alkyl aromatics and aldehydes. Chem. Commun. 2012, 48, 5491–5493. [Google Scholar] [CrossRef]
- Dal Zotto, C.; Michaux, J.; Zarate-Ruiz, A.; Gayon, E.; Virieux, D.; Campagne, J.M.; Terrasson, V.; Pieters, G.; Gaucher, A.; Prim, D. FeCl3-catalyzed addition of nitrogen and 1,3-dicarbonyl nucleophiles to olefins. J. Organomet. Chem. 2011, 696, 296–304. [Google Scholar] [CrossRef]
- Fu, W.; Shen, R.; Bai, E.; Zhang, L.; Chen, Q.; Fang, Z.; Li, G.; Yi, X.; Zheng, A.; Tang, T. Reaction route and mechanism of the direct N-alkylation of sulfonamides on acidic mesoporous zeolite β-catalyst. ACS Catal. 2018, 8, 9043–9055. [Google Scholar] [CrossRef]
- Yadav, J.S.; Reddy, B.S.; Rao, T.S.; Krishna, B.B.M. Iodine-catalyzed intermolecular hydroamination of vinyl arenes. Tetrahedron Lett. 2009, 50, 5351–5353. [Google Scholar]
- Noji, M.; Ohno, T.; Fuji, K.; Futaba, N.; Tajima, H.; Ishii, K. Secondary benzylation using benzyl alcohols catalyzed by lanthanoid, scandium, and hafnium triflate. J. Org. Chem. 2003, 68, 9340–9347. [Google Scholar] [CrossRef]
- Kim, H.K.; Park, Y.D.; Kim, J.J.; Lee, M.H.; Chung, H.A.; Kweon, D.H.; Cho, S.D.; Yoon, Y.J. Chemoselective N-benzenesulfonylation of aliphatic amines. Bull. Korean Chem. Soc. 2003, 24, 1655–1658. [Google Scholar]
- Giner, X.; Najera, C. (Triphenyl phosphite) gold (I)-catalyzed intermolecular hydroamination of alkenes and 1,3-dienes. Org. Lett. 2008, 10, 2919–2922. [Google Scholar]
- Yang, L.; Xu, L.W.; Xia, C.G. Highly Efficient and Reusable Ionic Liquids for the Catalyzed Hydroamination of Alkenes with Sulfonamides, Carbamates, and Carboxamides. Synthesis 2009, 2009, 1969–1974. [Google Scholar] [CrossRef]
In Vitro Activity | Lipinski’s Rule of Five | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Compound | Trypanocide IC50 (μM) | Cytotoxicity CC50 (μM) | SI | HBA | HBD | MW (g·mol−1) | log P | Violations | TPSA (A2) | Volume A3 | NRB |
1a | 109 ± 2 | 145 ± 2 | 1.3 | 3 | 1 | 276.11 | 3.41 | 0 | 46.17 | 249.24 | 4 |
1aa | 116 ± 1 | 290 ± 3 | 2.5 | 3 | 1 | 276.11 | 3.41 | 0 | 46.17 | 249.24 | 4 |
1b | 48 ± 1 | 273 ± 2 | 5.7 | 3 | 1 | 293.36 | 3.58 | 0 | 46.17 | 254.17 | 4 |
1c | 39 ± 1 | 129 ± 2 | 3.3 | 3 | 1 | 309.82 | 4.09 | 0 | 46.17 | 262.77 | 4 |
1d | 45 ± 1 | 138 ± 2 | 3.1 | 3 | 1 | 289.40 | 3.86 | 0 | 46.17 | 265.80 | 4 |
1e | 26 ± 1 | 138 ± 2 | 5.3 | 3 | 1 | 303.43 | 4.24 | 0 | 46.17 | 282.36 | 4 |
1f | 28 ± 1 | 123 ± 2 | 4.4 | 3 | 1 | 325.43 | 4.60 | 0 | 46.17 | 293.23 | 4 |
1g | 101 ± 1 | 254 ± 3 | 2.5 | 6 | 1 | 306.34 | 2.92 | 0 | 91.99 | 256.01 | 5 |
1h | 22 ± 1 | 118 ± 2 | 5.4 | 6 | 1 | 340.79 | 3.60 | 0 | 91.99 | 269.55 | 5 |
1i | 34 ± 1 | 91 ± 1 | 2.6 | 6 | 1 | 320.37 | 3.37 | 0 | 91.99 | 272.57 | 5 |
1j | 22 ± 1 | 120 ± 2 | 5.4 | 6 | 1 | 334.40 | 3.75 | 0 | 91.99 | 289.13 | 5 |
1k | 30 ± 1 | 159 ± 2 | 5.3 | 6 | 1 | 296.35 | 2.50 | 0 | 91.99 | 247.22 | 4 |
1l | 116 ± 3 | 301 ± 5 | 2.6 | 3 | 1 | 265.38 | 2.99 | 0 | 46.17 | 240.44 | 3 |
1m | 27 ± 1 | 169 ± 2 | 6.4 | 3 | 0 | 355.50 | 4.63 | 0 | 37.38 | 329.04 | 5 |
Bnz | 3.81 | 2381 | 625 | - | - | 260.25 | 0.78 | 0 | 92.75 | 224.99 | 5 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Junior, P.A.S.; Murta, S.M.F.; Taylor, J.G. In Vitro Evaluation of Arylsulfonamide Derivatives against Trypanosoma cruzi. Drugs Drug Candidates 2023, 2, 477-485. https://doi.org/10.3390/ddc2020024
Junior PAS, Murta SMF, Taylor JG. In Vitro Evaluation of Arylsulfonamide Derivatives against Trypanosoma cruzi. Drugs and Drug Candidates. 2023; 2(2):477-485. https://doi.org/10.3390/ddc2020024
Chicago/Turabian StyleJunior, Policarpo Ademar Sales, Silvane Maria Fonseca Murta, and Jason Guy Taylor. 2023. "In Vitro Evaluation of Arylsulfonamide Derivatives against Trypanosoma cruzi" Drugs and Drug Candidates 2, no. 2: 477-485. https://doi.org/10.3390/ddc2020024